About: Real‐world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID‐19 disease) in patients with Multiple Myeloma receiving systemic anti‐cancer therapy.

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Real‐world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID‐19 disease) in patients with Multiple Myeloma receiving systemic anti‐cancer therapy. Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Real‐world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID‐19 disease) in patients with Multiple Myeloma receiving systemic anti‐cancer therapy.
Creator	Pratt, Guy Kaiser, Martin Cook, Gordon Ramasamy, Karthik Soutar, Richard Ashcroft, A Bygrave, Ceri Hall, Rachel Henshaw, Sarah Jackson, Graham Jenner, Matthew Popat, Rakesh Rabin, Neil Sive, Jonathan Stern, Simon Streetly, Matthew
source	Medline; PMC
abstract	Infection with the novel coronavirus SARS‐CoV‐2 virus resulting in an acute respiratory disease (COVID‐19 disease) is the cause of the current pneumonia pandemic, with a rapid rise in cases being reported in the European Union and UK (1, 2). The UK index case was identified on the 31(st) of January, 2020 and given the rapid spread and high mortality rate of COVID‐19, it is imperative to define the impact on patients with co‐existing medical conditions(3).
has issue date	2020-05-21(xsd:dateTime)
bibo:doi	10.1111/bjh.16874
bibo:pmid	32438482
has license	no-cc
sha1sum (hex)	a42f845b87d0898e443e1f7452709a2421516b02
schema:url	https://doi.org/10.1111/bjh.16874
resource representing a document's title	Real‐world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID‐19 disease) in patients with Multiple Myeloma receiving systemic anti‐cancer therapy.
has PubMed Central identifier	PMC7280609
has PubMed identifier	32438482
schema:publication	Br J Haematol
resource representing a document's body	covid:a42f845b87d0898e443e1f7452709a2421516b02#body_text
is schema:about of	named entity 'Multiple Myeloma' named entity 'patients' named entity 'COVID-19 disease' named entity 'symptomatic infection' named entity 'Multiple Myeloma' named entity 'RRMM' named entity 'clinical practice' named entity '8.5' named entity 'B-cell' named entity 'COVID-19' named entity 'medical conditions' named entity 'COVID-19 infection' named entity 'sub-class' named entity 'respiratory tract' named entity 'RRMM' named entity 'chest radiograph' named entity 'COVID-19' named entity 'blood cancers' named entity 'refractory disease' named entity 'COVID-19' named entity 'COVID-19 pandemic' named entity 'outpatient setting' named entity 'medical conditions' named entity 'COVID-19' named entity 'COVID-19' named entity 'immune suppression' named entity 'comorbidity' named entity 'Hypertension' named entity 'secondary care' named entity 'hydroxychloroquine' named entity 'COVID-19' named entity 'SACT' named entity 'mortality rate' named entity 'primary care' named entity 'Index case' named entity 'COVID-19' named entity 'Afro-Caribbean' named entity 'COVID-19' named entity 'clinical trials' named entity 'anti-cancer' named entity 'infection' named entity 'ruxolitinib' named entity 'COVID-19' named entity 'cough' named entity 'COVID-19' named entity 'mortality rate' named entity 'COVID-19' named entity 'COVID-19' named entity 'absolute lymphocyte count' named entity 'comorbidity' named entity 'haematological malignancy' named entity 'Multiple Myeloma' named entity 'COVID-19' named entity 'COVID-19' named entity 'symptom' named entity 'comorbidities' named entity 'data.gov.uk' named entity 'mortality rate' named entity 'LoS' named entity 'supportive care' named entity 'COVID-19 infection' named entity 'tumour' named entity 'COVID-19' named entity 'symptom' named entity 'secondary care' named entity 'significant difference'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software